Preload Image
Preload Image
Report Store mobile icon
Global Orally Disintegrating Tablet (ODT) Market Growth 2024-2030

Global Orally Disintegrating Tablet (ODT) Market Growth 2024-2030

2024

Global Orally Disintegrating Tablet (ODT) Market Growth 2024-2030

The global orally disintegrating tablet (ODT) market is valued at US$ 13.59 billion in 2024, with growing demand for convenient pharmaceutical formulations.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global orally disintegrating tablet (ODT) market has seen substantial growth in recent years, primarily due to the increasing demand for convenient and patient-friendly drug delivery systems. ODTs are designed to rapidly disintegrate in the mouth without the need for water, making them especially useful for patients who have difficulty swallowing traditional tablets or capsules, such as the elderly, children, and individuals with swallowing disorders like dysphagia. These tablets are typically formulated with excipients that facilitate quick disintegration, allowing for the active pharmaceutical ingredient to be absorbed more rapidly into the bloodstream, leading to faster therapeutic effects. As such, the global demand for ODTs has surged due to their ability to provide quick and efficient medication delivery, improving patient compliance and overall treatment outcomes. The rise in chronic diseases such as diabetes, hypertension, and neurological disorders has further bolstered the need for easy-to-administer drug formulations, as many patients find it challenging to take traditional oral medications. Additionally, advances in pharmaceutical technology have enabled the development of ODTs with improved taste masking and enhanced stability, addressing previous limitations and widening their appeal. The ODT market has also benefitted from the growing trend of self-medication, with over-the-counter ODT products gaining popularity for conditions such as headaches, allergies, and indigestion. Furthermore, the increasing focus on patient-centric drug delivery systems has driven pharmaceutical companies to invest in the development of ODT technology, resulting in a broad range of ODT-based formulations for various therapeutic areas. This patient-friendly approach to drug administration has contributed to the sustained growth of the ODT market and its potential for further expansion in the global pharmaceutical industry.

According to Publisher, global Orally Disintegrating Tablet (ODT) market size was valued at US$ 13590 million in 2024. With growing demand in downstream market, the Orally Disintegrating Tablet (ODT) is forecast to a readjusted size of US$ 17440 million by 2030 with a CAGR of 3.6% during review period. The North American and European regions have been leading the global orally disintegrating tablet (ODT) market, supported by well-established healthcare infrastructures and a high rate of adoption of advanced drug delivery systems. In these regions, the demand for ODTs is primarily driven by the increasing number of patients with chronic conditions and the aging population, both of which require medications that are easier to ingest. As the elderly population in these regions continues to grow, the need for drug delivery systems that simplify medication administration has become more pronounced, leading to the increased use of ODTs. Moreover, the strong presence of major pharmaceutical companies in North America and Europe has led to significant investments in the research and development of ODT technologies, with an emphasis on improving the bioavailability, stability, and dissolution properties of these tablets. The availability of a diverse range of ODT products, including those designed for rapid disintegration and enhanced taste masking, has contributed to the widespread adoption of these tablets among patients. Additionally, the rising awareness of the benefits of ODTs has led to a growing market for over-the-counter ODT products, which are used for conditions such as pain relief, allergies, and digestive issues. Meanwhile, the Asia Pacific region is expected to experience significant growth in the ODT market in the coming years, fueled by the increasing demand for advanced healthcare solutions and the expanding healthcare access in countries like India, China, and Japan. The large population base and the rising prevalence of chronic diseases in these countries present substantial opportunities for ODT manufacturers. Furthermore, the affordability and ease of use of ODTs make them an attractive option for emerging markets, where they are expected to gain traction as pharmaceutical companies continue to introduce cost-effective ODT formulations to cater to local needs.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The orally disintegrating tablet (ODT) market can be segmented by types, with two primary categories: conventional ODTs and fast-dissolving ODTs. Conventional ODTs are designed to disintegrate in the mouth within seconds, typically within 30 seconds to a minute, making them suitable for drugs that do not require an immediate onset of action. These tablets are often used for over-the-counter products, such as pain relievers, antacids, and antihistamines, where rapid absorption is not as critical. The conventional ODT formulation is widely adopted due to its simplicity, ease of manufacture, and the ability to address the needs of patients who have difficulty swallowing traditional oral dosage forms. In contrast, fast-dissolving ODTs are engineered for rapid disintegration and absorption, providing a quicker onset of action. These tablets are particularly beneficial in situations where patients need fast relief from symptoms, such as in the treatment of migraines, nausea, and acute pain conditions. Fast-dissolving ODTs typically have higher levels of disintegration and absorption due to the inclusion of specialized excipients that enhance the rate of dissolution. These tablets are favored in the pharmaceutical sector for prescription medications that require quick therapeutic effects, offering a practical solution for patients who need immediate relief. The choice between conventional and fast-dissolving ODTs depends on the therapeutic needs of the patient and the specific requirements of the drug. Fast-dissolving ODTs have gained significant popularity due to the growing demand for quick and effective drug delivery systems, and they are expected to continue driving the growth of the ODT market as new advancements in formulation technology emerge.

The market for orally disintegrating tablets (ODTs) is also segmented by applications, with key therapeutic areas including central nervous system (CNS) disorders, gastrointestinal (GI) disorders, and other medical conditions such as cardiovascular and respiratory diseases. ODTs have found significant utility in the treatment of CNS disorders, where fast absorption is crucial. For conditions like migraine, anxiety, depression, and nausea, rapid onset of action is essential to provide quick relief from symptoms. ODT formulations are particularly advantageous in these cases, as they offer faster absorption and more efficient drug delivery compared to traditional tablets, which may require water and take longer to dissolve in the stomach. In the GI segment, ODTs are increasingly used to treat conditions such as acid reflux, nausea, and irritable bowel syndrome, where patients often experience difficulty swallowing pills due to discomfort. The easy-to-administer nature of ODTs makes them an appealing option for these patients, as they do not require water for ingestion, and they begin working almost immediately after disintegration. In addition to CNS and GI disorders, ODTs are being explored for use in treating cardiovascular and respiratory diseases, where quick delivery of medications is often needed to alleviate acute symptoms. For example, in the case of acute asthma exacerbations or cardiovascular emergencies, ODTs can provide fast relief by rapidly delivering the active ingredient. As patient-centric drug delivery systems continue to gain traction, ODTs are increasingly being recognized for their potential across a wide range of therapeutic areas, leading to a growing market for these convenient and efficient dosage forms. The versatility of ODTs in addressing various medical conditions has further fueled their adoption, making them a valuable addition to modern pharmaceutical treatments.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Orally Disintegrating Tablet (ODT) Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Orally Disintegrating Tablet (ODT) by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Orally Disintegrating Tablet (ODT) by Country/Region, 2019, 2023 & 2030
  • 2.2 Orally Disintegrating Tablet (ODT) Segment by Type
  • 2.2.1 Anti-Psychotics Drug
  • 2.2.2 Anti-Epileptics Drug
  • 2.2.3 Others
  • 2.3 Orally Disintegrating Tablet (ODT) Sales by Type
  • 2.3.1 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Orally Disintegrating Tablet (ODT) Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Orally Disintegrating Tablet (ODT) Sale Price by Type (2019-2024)
  • 2.4 Orally Disintegrating Tablet (ODT) Segment by Application
  • 2.4.1 CNS Diseases
  • 2.4.2 Gastrointestinal Diseases
  • 2.4.3 CVS Diseases
  • 2.4.4 Others
  • 2.5 Orally Disintegrating Tablet (ODT) Sales by Application
  • 2.5.1 Global Orally Disintegrating Tablet (ODT) Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Orally Disintegrating Tablet (ODT) Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Orally Disintegrating Tablet (ODT) Sale Price by Application (2019-2024)
  • 3 Global Orally Disintegrating Tablet (ODT) by Company
  • 3.1 Global Orally Disintegrating Tablet (ODT) Breakdown Data by Company
  • 3.1.1 Global Orally Disintegrating Tablet (ODT) Annual Sales by Company (2019-2024)
  • 3.1.2 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Company (2019-2024)
  • 3.2 Global Orally Disintegrating Tablet (ODT) Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Orally Disintegrating Tablet (ODT) Revenue by Company (2019-2024)
  • 3.2.2 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Company (2019-2024)
  • 3.3 Global Orally Disintegrating Tablet (ODT) Sale Price by Company
  • 3.4 Key Manufacturers Orally Disintegrating Tablet (ODT) Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Orally Disintegrating Tablet (ODT) Product Location Distribution
  • 3.4.2 Players Orally Disintegrating Tablet (ODT) Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Orally Disintegrating Tablet (ODT) by Geographic Region
  • 4.1 World Historic Orally Disintegrating Tablet (ODT) Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Orally Disintegrating Tablet (ODT) Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Orally Disintegrating Tablet (ODT) Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Orally Disintegrating Tablet (ODT) Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Orally Disintegrating Tablet (ODT) Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Orally Disintegrating Tablet (ODT) Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Orally Disintegrating Tablet (ODT) Sales Growth
  • 4.4 APAC Orally Disintegrating Tablet (ODT) Sales Growth
  • 4.5 Europe Orally Disintegrating Tablet (ODT) Sales Growth
  • 4.6 Middle East & Africa Orally Disintegrating Tablet (ODT) Sales Growth
  • 5 Americas
  • 5.1 Americas Orally Disintegrating Tablet (ODT) Sales by Country
  • 5.1.1 Americas Orally Disintegrating Tablet (ODT) Sales by Country (2019-2024)
  • 5.1.2 Americas Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2024)
  • 5.2 Americas Orally Disintegrating Tablet (ODT) Sales by Type
  • 5.3 Americas Orally Disintegrating Tablet (ODT) Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Orally Disintegrating Tablet (ODT) Sales by Region
  • 6.1.1 APAC Orally Disintegrating Tablet (ODT) Sales by Region (2019-2024)
  • 6.1.2 APAC Orally Disintegrating Tablet (ODT) Revenue by Region (2019-2024)
  • 6.2 APAC Orally Disintegrating Tablet (ODT) Sales by Type
  • 6.3 APAC Orally Disintegrating Tablet (ODT) Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Orally Disintegrating Tablet (ODT) by Country
  • 7.1.1 Europe Orally Disintegrating Tablet (ODT) Sales by Country (2019-2024)
  • 7.1.2 Europe Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2024)
  • 7.2 Europe Orally Disintegrating Tablet (ODT) Sales by Type
  • 7.3 Europe Orally Disintegrating Tablet (ODT) Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Orally Disintegrating Tablet (ODT) by Country
  • 8.1.1 Middle East & Africa Orally Disintegrating Tablet (ODT) Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Orally Disintegrating Tablet (ODT) Sales by Type
  • 8.3 Middle East & Africa Orally Disintegrating Tablet (ODT) Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet (ODT)
  • 10.3 Manufacturing Process Analysis of Orally Disintegrating Tablet (ODT)
  • 10.4 Industry Chain Structure of Orally Disintegrating Tablet (ODT)
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Orally Disintegrating Tablet (ODT) Distributors
  • 11.3 Orally Disintegrating Tablet (ODT) Customer
  • 12 World Forecast Review for Orally Disintegrating Tablet (ODT) by Geographic Region
  • 12.1 Global Orally Disintegrating Tablet (ODT) Market Size Forecast by Region
  • 12.1.1 Global Orally Disintegrating Tablet (ODT) Forecast by Region (2025-2030)
  • 12.1.2 Global Orally Disintegrating Tablet (ODT) Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Orally Disintegrating Tablet (ODT) Forecast by Type
  • 12.7 Global Orally Disintegrating Tablet (ODT) Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Teva
  • 13.1.1 Teva Company Information
  • 13.1.2 Teva Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.1.3 Teva Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Teva Main Business Overview
  • 13.1.5 Teva Latest Developments
  • 13.2 Merck
  • 13.2.1 Merck Company Information
  • 13.2.2 Merck Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.2.3 Merck Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Merck Main Business Overview
  • 13.2.5 Merck Latest Developments
  • 13.3 Mylan
  • 13.3.1 Mylan Company Information
  • 13.3.2 Mylan Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.3.3 Mylan Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Mylan Main Business Overview
  • 13.3.5 Mylan Latest Developments
  • 13.4 Pfizer
  • 13.4.1 Pfizer Company Information
  • 13.4.2 Pfizer Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.4.3 Pfizer Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Pfizer Main Business Overview
  • 13.4.5 Pfizer Latest Developments
  • 13.5 Johnson and Johnson
  • 13.5.1 Johnson and Johnson Company Information
  • 13.5.2 Johnson and Johnson Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.5.3 Johnson and Johnson Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Johnson and Johnson Main Business Overview
  • 13.5.5 Johnson and Johnson Latest Developments
  • 13.6 GSK
  • 13.6.1 GSK Company Information
  • 13.6.2 GSK Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.6.3 GSK Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 GSK Main Business Overview
  • 13.6.5 GSK Latest Developments
  • 13.7 Otsuka
  • 13.7.1 Otsuka Company Information
  • 13.7.2 Otsuka Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.7.3 Otsuka Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Otsuka Main Business Overview
  • 13.7.5 Otsuka Latest Developments
  • 13.8 Eli Lilly and Company
  • 13.8.1 Eli Lilly and Company Company Information
  • 13.8.2 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.8.3 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Eli Lilly and Company Main Business Overview
  • 13.8.5 Eli Lilly and Company Latest Developments
  • 13.9 AstraZeneca
  • 13.9.1 AstraZeneca Company Information
  • 13.9.2 AstraZeneca Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.9.3 AstraZeneca Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 AstraZeneca Main Business Overview
  • 13.9.5 AstraZeneca Latest Developments
  • 13.10 Bristol-Myers Squibb
  • 13.10.1 Bristol-Myers Squibb Company Information
  • 13.10.2 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 Bristol-Myers Squibb Main Business Overview
  • 13.10.5 Bristol-Myers Squibb Latest Developments
  • 13.11 Conquer
  • 13.11.1 Conquer Company Information
  • 13.11.2 Conquer Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
  • 13.11.3 Conquer Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 Conquer Main Business Overview
  • 13.11.5 Conquer Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Orally Disintegrating Tablet (ODT) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Orally Disintegrating Tablet (ODT) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-Psychotics Drug
Table 4. Major Players of Anti-Epileptics Drug
Table 5. Major Players of Others
Table 6. Global Orally Disintegrating Tablet (ODT) Sales by Type (2019-2024) & (K Units)
Table 7. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2024)
Table 8. Global Orally Disintegrating Tablet (ODT) Revenue by Type (2019-2024) & ($ million)
Table 9. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type (2019-2024)
Table 10. Global Orally Disintegrating Tablet (ODT) Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Orally Disintegrating Tablet (ODT) Sales by Application (2019-2024) & (K Units)
Table 12. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2019-2024)
Table 13. Global Orally Disintegrating Tablet (ODT) Revenue by Application (2019-2024)
Table 14. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Application (2019-2024)
Table 15. Global Orally Disintegrating Tablet (ODT) Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Orally Disintegrating Tablet (ODT) Sales by Company (2019-2024) & (K Units)
Table 17. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Company (2019-2024)
Table 18. Global Orally Disintegrating Tablet (ODT) Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Company (2019-2024)
Table 20. Global Orally Disintegrating Tablet (ODT) Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Orally Disintegrating Tablet (ODT) Producing Area Distribution and Sales Area
Table 22. Players Orally Disintegrating Tablet (ODT) Products Offered
Table 23. Orally Disintegrating Tablet (ODT) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Orally Disintegrating Tablet (ODT) Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Orally Disintegrating Tablet (ODT) Sales Market Share Geographic Region (2019-2024)
Table 28. Global Orally Disintegrating Tablet (ODT) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Orally Disintegrating Tablet (ODT) Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Country/Region (2019-2024)
Table 32. Global Orally Disintegrating Tablet (ODT) Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Orally Disintegrating Tablet (ODT) Sales by Country (2019-2024) & (K Units)
Table 35. Americas Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2019-2024)
Table 36. Americas Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2019-2024)
Table 38. Americas Orally Disintegrating Tablet (ODT) Sales by Type (2019-2024) & (K Units)
Table 39. Americas Orally Disintegrating Tablet (ODT) Sales by Application (2019-2024) & (K Units)
Table 40. APAC Orally Disintegrating Tablet (ODT) Sales by Region (2019-2024) & (K Units)
Table 41. APAC Orally Disintegrating Tablet (ODT) Sales Market Share by Region (2019-2024)
Table 42. APAC Orally Disintegrating Tablet (ODT) Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Orally Disintegrating Tablet (ODT) Revenue Market Share by Region (2019-2024)
Table 44. APAC Orally Disintegrating Tablet (ODT) Sales by Type (2019-2024) & (K Units)
Table 45. APAC Orally Disintegrating Tablet (ODT) Sales by Application (2019-2024) & (K Units)
Table 46. Europe Orally Disintegrating Tablet (ODT) Sales by Country (2019-2024) & (K Units)
Table 47. Europe Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2019-2024)
Table 48. Europe Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2019-2024)
Table 50. Europe Orally Disintegrating Tablet (ODT) Sales by Type (2019-2024) & (K Units)
Table 51. Europe Orally Disintegrating Tablet (ODT) Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Orally Disintegrating Tablet (ODT)
Table 59. Key Market Challenges & Risks of Orally Disintegrating Tablet (ODT)
Table 60. Key Industry Trends of Orally Disintegrating Tablet (ODT)
Table 61. Orally Disintegrating Tablet (ODT) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Orally Disintegrating Tablet (ODT) Distributors List
Table 64. Orally Disintegrating Tablet (ODT) Customer List
Table 65. Global Orally Disintegrating Tablet (ODT) Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Orally Disintegrating Tablet (ODT) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Orally Disintegrating Tablet (ODT) Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Orally Disintegrating Tablet (ODT) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Orally Disintegrating Tablet (ODT) Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Orally Disintegrating Tablet (ODT) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Orally Disintegrating Tablet (ODT) Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Orally Disintegrating Tablet (ODT) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Orally Disintegrating Tablet (ODT) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Orally Disintegrating Tablet (ODT) Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Orally Disintegrating Tablet (ODT) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Orally Disintegrating Tablet (ODT) Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Orally Disintegrating Tablet (ODT) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Teva Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 81. Teva Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Merck Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 86. Merck Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Mylan Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 91. Mylan Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Pfizer Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 96. Pfizer Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Johnson and Johnson Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson and Johnson Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 101. Johnson and Johnson Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Johnson and Johnson Main Business
Table 103. Johnson and Johnson Latest Developments
Table 104. GSK Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 105. GSK Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 106. GSK Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. GSK Main Business
Table 108. GSK Latest Developments
Table 109. Otsuka Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 110. Otsuka Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 111. Otsuka Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Otsuka Main Business
Table 113. Otsuka Latest Developments
Table 114. Eli Lilly and Company Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly and Company Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 116. Eli Lilly and Company Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Eli Lilly and Company Main Business
Table 118. Eli Lilly and Company Latest Developments
Table 119. AstraZeneca Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 120. AstraZeneca Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 121. AstraZeneca Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. AstraZeneca Main Business
Table 123. AstraZeneca Latest Developments
Table 124. Bristol-Myers Squibb Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 125. Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 126. Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Bristol-Myers Squibb Main Business
Table 128. Bristol-Myers Squibb Latest Developments
Table 129. Conquer Basic Information, Orally Disintegrating Tablet (ODT) Manufacturing Base, Sales Area and Its Competitors
Table 130. Conquer Orally Disintegrating Tablet (ODT) Product Portfolios and Specifications
Table 131. Conquer Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Conquer Main Business
Table 133. Conquer Latest Developments
List of


Figure 1. Picture of Orally Disintegrating Tablet (ODT)
Figure 2. Orally Disintegrating Tablet (ODT) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orally Disintegrating Tablet (ODT) Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Orally Disintegrating Tablet (ODT) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Orally Disintegrating Tablet (ODT) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-Psychotics Drug
Figure 10. Product Picture of Anti-Epileptics Drug
Figure 11. Product Picture of Others
Figure 12. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type in 2023
Figure 13. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type (2019-2024)
Figure 14. Orally Disintegrating Tablet (ODT) Consumed in CNS Diseases
Figure 15. Global Orally Disintegrating Tablet (ODT) Market: CNS Diseases (2019-2024) & (K Units)
Figure 16. Orally Disintegrating Tablet (ODT) Consumed in Gastrointestinal Diseases
Figure 17. Global Orally Disintegrating Tablet (ODT) Market: Gastrointestinal Diseases (2019-2024) & (K Units)
Figure 18. Orally Disintegrating Tablet (ODT) Consumed in CVS Diseases
Figure 19. Global Orally Disintegrating Tablet (ODT) Market: CVS Diseases (2019-2024) & (K Units)
Figure 20. Orally Disintegrating Tablet (ODT) Consumed in Others
Figure 21. Global Orally Disintegrating Tablet (ODT) Market: Others (2019-2024) & (K Units)
Figure 22. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2023)
Figure 23. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Application in 2023
Figure 24. Orally Disintegrating Tablet (ODT) Sales Market by Company in 2023 (K Units)
Figure 25. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Company in 2023
Figure 26. Orally Disintegrating Tablet (ODT) Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Company in 2023
Figure 28. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Orally Disintegrating Tablet (ODT) Sales 2019-2024 (K Units)
Figure 31. Americas Orally Disintegrating Tablet (ODT) Revenue 2019-2024 ($ Millions)
Figure 32. APAC Orally Disintegrating Tablet (ODT) Sales 2019-2024 (K Units)
Figure 33. APAC Orally Disintegrating Tablet (ODT) Revenue 2019-2024 ($ Millions)
Figure 34. Europe Orally Disintegrating Tablet (ODT) Sales 2019-2024 (K Units)
Figure 35. Europe Orally Disintegrating Tablet (ODT) Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Orally Disintegrating Tablet (ODT) Revenue 2019-2024 ($ Millions)
Figure 38. Americas Orally Disintegrating Tablet (ODT) Sales Market Share by Country in 2023
Figure 39. Americas Orally Disintegrating Tablet (ODT) Revenue Market Share by Country in 2023
Figure 40. Americas Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2024)
Figure 41. Americas Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2019-2024)
Figure 42. United States Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Orally Disintegrating Tablet (ODT) Sales Market Share by Region in 2023
Figure 47. APAC Orally Disintegrating Tablet (ODT) Revenue Market Share by Regions in 2023
Figure 48. APAC Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2024)
Figure 49. APAC Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2019-2024)
Figure 50. China Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Orally Disintegrating Tablet (ODT) Sales Market Share by Country in 2023
Figure 58. Europe Orally Disintegrating Tablet (ODT) Revenue Market Share by Country in 2023
Figure 59. Europe Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2024)
Figure 60. Europe Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2019-2024)
Figure 61. Germany Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Orally Disintegrating Tablet (ODT) Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2019-2024)
Figure 70. Egypt Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Orally Disintegrating Tablet (ODT) Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet (ODT) in 2023
Figure 76. Manufacturing Process Analysis of Orally Disintegrating Tablet (ODT)
Figure 77. Industry Chain Structure of Orally Disintegrating Tablet (ODT)
Figure 78. Channels of Distribution
Figure 79. Global Orally Disintegrating Tablet (ODT) Sales Market Forecast by Region (2025-2030)
Figure 80. Global Orally Disintegrating Tablet (ODT) Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Orally Disintegrating Tablet (ODT) Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Orally Disintegrating Tablet (ODT) Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Orally Disintegrating Tablet (ODT) Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Orally Disintegrating Tablet (ODT) Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Orally Disintegrating Tablet (ODT) Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.